Specifically, ADRB2 polymorphisms were associated with glaucoma in an Indian population [52], and in Japanese patients [54] and were also found to correlate to increased therapeutical response to β-blockers eye drops, used for the treatment of ocular hypertension [55]. This evidence concerns the gene ADRB2 and ocular hypertension.